As the American Diabetes Association’s (ADA) 77th Scientific Sessions coming close, Primeds’ CEO dr. Wen Zeng, CSO dr. Fabao Gao and chief consultant dr. Barbara C. Hansen attended this meeting and discussed with scientists from big pharmas and research institutions such as Joslin Diabetes Center and Isareli National Council of Diabetes about the latest research projects in diabetic kidney disease, chronic heart failure and diabetic foot as well as latest research findings of Primed team. During the sessions, dr. Wen Zeng and professor Barbara C. Hansen were invited to Joslin ADA Reception held by Joslin Diabetes Center, which affiliated with Harvard Medical School.
Primed CSO professor Fabao Gao was interviewed by Dingxiangyuan(DXY) and shred our latest research in diabetic foot-evaluation of the Alteration of Slow- and Fast-Twitch Muscles to Type 2 Diabetes in monkeys by MRI. Our studies presented as ADA scientific sessions received attentions and praises of big pharma and research institutions such as Joslin Diabetes Center and Isaraeli National Council of Diabetes.

Research Highlights
    Non-human primate models with diabetic complications and the models’ applications: chronic heart failure, myocardial diffuse fibrosis quantification by cardiac MRI, diabetic kidney disease, diabetic foot, diabetic retinopathy and hypertension.